Li, Haoxin
Ning, Shaoyang
Ghandi, Mahmoud http://orcid.org/0000-0003-1897-2265
Kryukov, Gregory V.
Gopal, Shuba
Deik, Amy
Souza, Amanda
Pierce, Kerry
Keskula, Paula
Hernandez, Desiree
Ann, Julie
Shkoza, Dojna
Apfel, Verena
Zou, Yilong
Vazquez, Francisca http://orcid.org/0000-0002-2857-4685
Barretina, Jordi
Pagliarini, Raymond A.
Galli, Giorgio G.
Root, David E. http://orcid.org/0000-0001-5122-861X
Hahn, William C. http://orcid.org/0000-0003-2840-9791
Tsherniak, Aviad http://orcid.org/0000-0002-3797-1877
Giannakis, Marios
Schreiber, Stuart L. http://orcid.org/0000-0003-1922-7558
Clish, Clary B. http://orcid.org/0000-0001-8259-9245
Garraway, Levi A.
Sellers, William R. http://orcid.org/0000-0003-2604-2498
Article History
Received: 2 October 2018
Accepted: 20 February 2019
First Online: 8 May 2019
Competing interests
: G.V.K. is an employee of and has equity in KSQ Therapeutics. G.V.K. is also a shareholder of Illumina and CRISPR Therapeutics. J.A., D.S., V.A., and G.G.G. are current Novartis employees. J.B. is a shareholder and former employee of Novartis. R.A.P. is a former employee of Novartis and a current employee of Celsius Therapeutics. W.C.H. is a consultant for Thermo-Fisher, Seer, AjuIB, MPM Capital, and KSQ Therapeutics and receives research funding from Deerfield Management. W.C.H. is a founder and has equity in KSQ Therapeutics. L.A.G. is a current employee at Eli Lilly and Company. A.T. is a consultant for Tango Therapeutics. M. Giannakis participated in an advisory board for Astrazeneca and receives research funding from Bristol-Myers Squibb. S.L.S. is a shareholder of Forma Therapeutics, a shareholder of and adviser to Jnana Therapeutics and Decibel Therapeutics, an adviser to Eisai, Inc. and F-Prime Capital Partners, and a Novartis Faculty Scholar. W.R.S. is a shareholder and former employee of Novartis. W.R.S. is a consultant and shareholder for Peloton Therapeutics and Ideaya Biosciences and is a consultant for Array, Astex, Ibsen, Servier, and Sanofi Pharmaceuticals and Epidarex Capital and receives research funding from Deerfield Management. H.L. and W.R.S. have a patent application based on this work. The other authors declare no competing interests.